Accelerated partial breast irradiation using external beam radiotherapy—A feasibility study based on dosimetric analysis  by Anbumani, Surega et al.
reports of practical oncology and radiotherapy 1 7 ( 2 0 1 2 ) 200–206
Available  online  at  www.sciencedirect.com
jo u r n al hom epage: ht tp : / /www.e lsev ier .com/ locate / rpor
Original research article
Accelerated  partial  breast  irradiation  using  external  beam
radiotherapy—A feasibility  study  based  on  dosimetric
analysis
Surega Anbumania,∗, Siddanna R. Palledb, Girish S. Prabhakara, N. Arunai Nambiraj c,
Anchineyan  Pichandia
a HCG-Bangalore Institute of Oncology, Bangalore, India
b Kidwai Memorial Institute of Oncology, Bangalore, India
c VIT University, Vellore, India
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 3 January 2012
Received in revised form
28  February 2012
Accepted 26 April 2012
Keywords:
APBI
Dose conformity
Dose homogeneity
Multicatheter ISBT
a  b  s  t  r  a  c  t
Aim: To investigate the feasibility of using External Beam radiotherapy for accelerated partial
breast irradiation by a comparative tumour and normal tissue dose volume analysis with
that of high dose rate interstitial brachytherapy.
Background: Accelerated Partial Breast Irradiation (APBI) is more clinically appealing because
of  the reduced treatment course duration and the irradiated area. Brachytherapy applica-
tion  is more dependent on the clinician’s expertise when it is practised free hand without
image guidance and a template. It happens to be an invasive procedure with the use of local
anaesthesia which adds patient discomfort apart from its cost compared to External Beam
Radiotherapy. But APBI with brachytherapy is more commonly practised procedure com-
pared to EBRT owing to its previous reults. Hence in this research study, we intend to explore
the  use of EBRT with the radiobiological corrections for APBI in the place of brachytherapy.
It  is done as a dosimetric comparison of Brachytherapy treatment plans with that of EBRT
plans.
Materials and methods: The computed tomography images of 15 patients undergoing ISBT
planning were simulated with conformal photon ﬁelds. Various dose volume parameters of
each  structure were obtained from the DVH generated in the brachytherapy and the sim-
ulated external beam planning which can correlate well with the late toxicity. The plan
quality indices such as conformity index and homogeneity index for the target volume werecomputed from the dosimetric factors. The statistical p values for CI, HI and normal tissue
dosimetric parameters were calculated and the conﬁdence levels achievable were analysed.
The dose prescribed in brachytherapy was 3400cGy in ten fractions. The equivalent prescrip-
tion  dose for the external beam radiotherapy planning was 3000cGy in ﬁve fractions applied
with radiobiological correction.
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All the ﬁfteen patients were with complete lung data and six were with left sided tumours
having complete cardiac data. The lung dosimetry data and the cardiac dosimetry data of
the  patients were studied. Lower percentages of lung and cardiac V20 and V5 volumes were
obtained with conformal planning. The conformity of radiation dose to the tumour volume
was  akin to the interstitial brachytherapy planning. Moreover the external beam planning
resulted in more homogenous dose distribution. For the sampled population, the statistical
analysis showed a conﬁdence level of 95% for using EBRT as an alternate to multi catheter
ISBT.
Conclusion: The EBRT planning for Accelerated Partial Breast Irradiation was found to be
technically feasible in the institution where the interstitial brachytherapy happens to be
the  only available technique as evident from the dose volume parameters and the statistical
analysis.
©  2012 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z.o.o. All
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a CT simulation for the treatment planning. The CT images
were sent to the PLATO treatment planning system (Ver-
sion 14.2.6. NucletronBV, the Netherlands). The Clinical Target
Table 1 – Patient selection.
Pt. no Age
(yrs)
Rx site Lesion
size
(cm)
No. of
negative
nodes
Surgical
margin
1 61 L Breast 3.0 20 −ve
2 70 R Breast 2.5 25 −ve
3 63 R Breast 1.9 20 −ve
4 65 R Breast 2.8 21 −ve
5 68 L Breast 3.0 23 −ve
6 71 L Breast 2.1 22 −ve
7 69 R Breast 2.7 25 −ve
8 70 R Breast 1.8 20 −ve
9 63 L Breast 1.6 23 −ve
10 61 L Breast 2.5 20 −ve
11 55 R Breast 3.0 22 −ve.  Background
ccelerated Partial Breast Irradiation (APBI) decreases the
uration of entire radiotherapy course.1 The reduced treat-
ent volume makes APBI more  appealing to both clinicians
nd patients. The uses of brachytherapy either as HDR or
DR interstitial implants have shown promising results which
re obvious from the published research works.2,3 But the
nterstitial implant technique can be more  complex and oper-
tor dependent. The implant application is usually done with
mage guidance (Ultra sound/mammography images) using a
emplate which plays a major role in ensuring uniform and
ccurate implants. Fewer oncologists prefer doing a free hand
pplication without a template guidance which needs more
xpertise.
Radiobiological models based comparison of APBI tech-
iques was done by Bovi J et al.4 Partial Breast Irradiation
echniques for early stage breast carcinoma were evaluated
y Agata et al.5 A dosimetric analysis was detailed by Cozzi
t al. as a clinical experience of 3D conformal partial breast
rradiation.6 Maia et al. and Vicini et al. studied the accelerated
artial breast irradiation using photon ﬁelds.7,8 Dosimetric
tudy of different accelerated partial breast irradiation tech-
iques, such as 3DCRT, IMRT  and Mammosite application, was
valuated by Khan AJ et al.9 Patel RR et al. dosimetrically com-
ared the 3DCRT APBI with that of multi catheter interstitial
mplant brachytherapy for prone and supine position in helical
omotherapy.10
.  Aim
n this study, we  explored the feasibility of using external
eam radiotherapy using three dimensional conformal pho-
on beams for APBI as an alternate practice to a freehand
nterstitial brachytherapy with dosimetrical and statisti-
al analysis. The comparison was done with interstitial
rachytherapy, since it is the only available APBI technique
racticed at the institution.rights reserved.
3.  Materials  and  methods
3.1.  Patient  selection
Fifteen patients undergoing the APBI with interstitial
brachytherapy technique were enrolled and approved for the
feasibility study.11 The patients underwent partial mastec-
tomy and negative sentinel lymph node biopsy or axillary
dissection for T1/T2 invasive duct carcinoma as a part of breast
conservation surgery between July 2009 and October 2011 (see
Table 1). Pre-treatment computed tomography images were
taken as guidance to assess the distance of the tumour bed
from the known landmarks or from the skin surface. The
distances were marked on the patient body. Flexible plastic
implant tubes were inserted into the tumour cavity as a free
hand application.
3.2.  Treatment  planning
After the insertion of interstitial tubes, the patients underwent12 58 R Breast 2.5 21 −ve
13 60 R Breast 2.7 24 −ve
14 62 R Breast 2.2 23 −ve
15 64 L Breast 1.2 22 −ve
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Table 2 – External beam plan parameters.
Pt. no Rx site No.of
beams
Energy Coplanar beams Non
coplanar
beams
Wedge Weightings
1 L Breast 7 6 MV 240,10,70,290 20–250
30–320
300–30
–  28:7:7:30:9:9:9
2 R Breast 5 6 MV 55,345,270,231,196 – 15,45,45,15,45 40:04:04:40:12
3 R Breast 4 6 MV 345,40,115,165 – – 28:24:24:24
4 R Breast 5 6 MV 40,0,280,230 270–320
20–250
266–35
300–30
30,30 20:20:20:20:20
5 L Breast 7 6 MV 225,275,0,60 45,30,30,45 28:7:7:30:9:9:9
6 L Breast 5 6 MV 320,357,141,160, 54 – 45,45,45 18:29:20:20:12
7 R Breast 6 6 MV 60,4,28,0,227 280–110
227–110
45,45,30,30 29:10:10:33:10
8 R Breast 6 6 MV 43,223,4,255 301–90
255–63
45,45 30:30:10:10:10:10
9 L Breast 5 6 MV 319,353,106,162, 55 15,45,45,15 15 32:12:12:33:12
10 L Breast 7 6 MV 238,8,60,280 20–245
30–320
298–25
–  27:8:8:29:9:9:9
11 R Breast 5 6 MV 50,340,270,230, 195 – 45,45,45,45,45,45 35:5:5:30:15
12 R Breast 4 6 MV 340,35,115,160 – – 20:20:20:20
13 R Breast 5 6 MV 53,345,270,235, 190 – 15,45,45,45 15 35:10:10:30:15
14 R Breast 6 6 MV 40,220,5,255 301–90
255–63
45,45 30:30:10:10:10:
, 155, 15 L Breast 5 6 MV 320,355,140
Volume was delineated as the lumpectomy cavity with a 2 cm
margin, modiﬁed to 5 mm deep anterior to skin surface and
also along the pectoral muscle.11 Critical organs such as ipsi-
lateral lung and heart for left sided tumour were also marked.
The contours were delineated by the same radiation oncolo-
gist. The catheters were reconstructed from skin entry to the
skin exit in the axial CT images. Dwell positions (step size
2.5 mm)  in the catheters were activated in such a way as to
fall within the CTV marked. Dose points were computed at
3 mm intervals on the CTV delineated. A dose of 340cGy was
prescribed to the target dose points. Then the volume based
dose optimisation was done (Fig. 1). The dose volume his-
tograms were generated for the target volumes and the critical
structures.
Fig. 1 – Multi catheter interstitial brachytherapy dose
distribution-axial view.53 – 45,45,45,45 20:20:30:15:15
With the implanted tubes in situ, an external beam ther-
apy course was planned in the same CT images. The multiple
beam arrangement was used with a combination of both
coplanar and non coplanar beams.12–14 The plan data was tab-
ulated in detail (Table 2). An optimal dose distribution with a
better coverage and homogeneity was achieved using typical
dose weightings with various wedge combination (Fig. 2). An
analysis conducted on BED of different fractionation schemes
based on available pre-clinical and clinical indications showed
that the tumour control in breast carcinoma can be effective
with a biological equivalent dose of 75 Gy.37 According to the
LQ model formula, a dose of 30 Gy given in ﬁve fractions of 6 Gy
over ten days was found to be radiobiologically equivalent in
tumour control (75 Gy) to that of 50 Gy/25 fractions over ﬁve
Fig. 2 – 3D conformal EBRT dose distribution-coronal view.
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were performed using Statistica 5.0 (Statsoft Inc) software to
assess the signiﬁcance of difference between the two groups.eeks.38 Hence, the dose prescribed was 600cGY × ﬁve frac-
ions calculated using linear quadratic cell survival model.15,16
he ﬁve fractions were simulated as an alternate day sched-
le over ten days. Dose volume histograms were generated
or all the structures (both target volume and normal tissues).
ince the same CT data sets were used for simulating the EBRT
lans, each patient served as their own internal control with
espect to anatomy.
.3.  Target  volume  dosimetry
rom the Dose Volume Histogram generated from the
rachytherapy plans (Fig. 3), the dosimetric parameters such
s V100, V150 and V′100 for the clinical target volume were
btained. Then the dose conformity index (CI) and the dose
Table 3 – CTV dosimetry.
Pt. no Interstitial brachytherapy planning 
V100 (cc) V150 (cc) V′100 (cc) Vref (cc) C.I. 
1 27.4 13.2 5.8 33.2 0.8253 
2 115.02 21.82 36.48 151.5 0.7592 
3 145.61 93.59 389 149.5 0.9739 
4 27.51 24.61 0.09 27.6 0.9967 
5 22.70 8.45 8.10 30.8 0.7370 
6 64.91 33.91 2.59 67.5 0.9616 
7 61.67 43.05 7.53 69.2 0.8911 
8 34.68 28.15 0.15 34.83 0.9956 
9 31.00 19.33 3.80 34.8 0.8908 
10 30.16 27.14 0.28 35.6 1.009 
11 40.12 30.49 5.64 44.16 1.163 
12 32.13 30.12 6.14 35.75 1.236 
13 28.6 10.12 4.1 30.14 1.167 
14 28.61 20.16 0.5 29.16 1.0178 
15 55.65 40.05 6.00 60.17 1.1208 
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homogeneity index (HI) for the CTV were calculated from Eqs.
(1) and (2) (Table 3).17
DHI = V100 − V150
V100
(1)
CI = V100
V100 − V′100
(2)
From the EBRT conformal plan dose volume histograms
(Fig. 4), the planning target volume (PTV), reference volume
(Vref), D2 and D98 were extracted. The dose conformity and
homogeneity index were calculated from the Dosimetric val-
ues from Eqs. (3) and (4) 18 and tabulated (Table 3).
HI = D2
D98
(3)
CI = PTV
Vref
(4)
3.4.  Normal  tissue  dosimetry
The dosimetric parameters such as Dmean, Dmax, D5 and V20
were obtained from the lung DVH generated in brachy plan-
ning and external beam planning (Table 3). The values of
D20 and D30 from the heart DVH were also obtained in addi-
tion to Dmean, Dmax, D5 and V20 (Table 4). These parameters
were taken into account since they correlate with late lung
toxicity in patients receiving radiotherapy.19–24,34–36 Cardiac
toxicity can be assessed with the available cardiac dosimetry
data.20,25–27,34,36
3.5. Statistical  analysis
A summation and a mean calculation were done for the out-The p values for target dose conformity, dose homogeneity and
External beam palnning
H.I. D2 (cGy) D98 (cGy) PTV (cc) C.I. H.I.
0.5182 30.94 28.22 25.5 0.768 1.096
0.8102 30.66 28.84 129.2 0.853 1.063
0.3572 32.70 29.52 134.5 0.900 1.107
0.1054 33.20 28.64 22.08 0.800 1.159
0.6277 31.78 28.14 26.55 0.862 1.129
0.4775 32.32 29.84 64.24 0.9665 1.083
0.3019 31.60 29.52 64.91 0.938 1.070
0.1882 31.40 27.79 28.8 0.827 1.129
0.3764 33.30 28.84 29.07 0.8355 1.154
0.1001 33.16 27.46 34.8 0.978 1.20
0.2400 32.12 28.48 43.89 0.994 1.128
0.0625 30.44 29.31 39.71 1.11 1.038
0.6462 32.60 30.10 32.55 1.08 1.083
0.2953 33.15 29.10 30.62 1.05 1.139
0.2803 31.48 27.64 59.51 0.989 1.138
0.3591 Mean 0.9301 1.114
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g-cumulative dose volume histogram.
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Plot 1 – Dose homogeneity index.Fig. 4 – 3D conformal EBRT plannin
normal tissue dosimetric parameters, such as Dmean, Dmax,
D5, V20, D20, D30 for the normal tissues were computed and
analysed (Table 4).
4.  Results
The EBRT plans resulted in a more  homogenous dose distri-
bution. It is evident from the homogeneity index (p = 7.255)
(Table 3 and Plot 1). The external beam planning resulted in
a conformal dose distribution which was comparable to that
of brachytherapy planning (p = 0.056) corresponding to a con-
ﬁdence interval of 95%. (Table 3 and Plot 2).
The incidental radiation dose to the lung and the heart
using EBRT planning was similar to that of ISBT. A conﬁdence
level of 95% was obtained with all the computed dosimetric
factors (D , D , D , V , D , V , V and D ) analysed,mean max 5 20 20 5 10 30
which supported the null hypothesis. Hence the normal tissue
dosimetry in terms of conformal external beam planning with
photon beams was comparable with brachy planning (Table 4).
Table 4 – Normal tissue dosimetry.
Dosimetric parameters External beam APBI ISBT APBI p-Value
Mean Range Mean Range
Lung n = 15
Dmean Gy 5.1 3.2–12.2 4.0 2.0–6.14 0.047
Dmax Gy 36.3 8.0–48.0 34.56 7.2–46.1 0.122
V30 (%) 0.5% 0–1% 0.4% 0.0–0.65% 0.107
V20 (%) 1.09% 0–3% 1.1% 0–2% 0.924
V10 (%) 10% 0–15% 8.5% 0–14.1% 0.141
D5 Gy 12.1 6.0–16 10.94 6.0–15.6 0.050
Heart n = 6
Dmean Gy 3.2 2.7–5.1 2.8 1.7–4.8 0.089
Dmax Gy 15.6 11.1–28.4 14.3 10.6–26.7 0.094
V20 (%) 0.15% 0–0.5% 0.11% 0.0–0.4% 0.047
V10 (%) 2.8% 0–8.2% 2.5% 0–8.0% 0.153
V5 (%) 20.8% 11.5–31.6% 19.5% 9.6–30.1% 0.608
D20 Gy 7.9 6.0–15.5 7.49 5.89–14.9 0.142
D30 Gy 7.27 6.8–10.4 7.0 6.0–9.9 0.218
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Brachytherapy 2006;5:183–8.
10. Patel RR, Becker SJ, Das RK, Mackie TR. A dosimetric. Discussion
rom this feasibility study, it was inferred that the simu-
ated EBRT plans gave low doses of radiation to the critical
rgans, such as the lung and heart, which was comparable
ith the brachy planning. EBRT planning with conformal pho-
on ﬁelds resulted in a very low percentage of volume receiving
 dose of 20 Gy having a conﬁdence level of 95% from the sam-
led population, which correlates with the lower incidence of
ung toxicity.26,28,29,31–35 There was no prominent difference in
eart maximum and minimum dose in both treatment plan-
ing techniques.
The dose conformity index (CI) and the dose homogeneity
ndex (HI) are the quality indicators of the best treatment plan.
onformity index measures the degree of conformity of the
adiation dose prescribed to the clinical target volume. Ideally,
I should be unity or the nearest value to unity in case of a bet-
er treatment plan. More  conformal dose distribution can be
chieved with the use of multiple photon beams which gives
n analogous dose distribution as brachytherapy treatment
lans (Table 3 and Plot 2).
Homogeneity index (HI) measures the radiation dose uni-
ormity in the clinical target volume. The HI values calculated
rom the EBRT plans showed the values nearing to one (Table 3
nd Plot 1), which is ideal for a homogenous dose distribution.
rachytherapy dose distributions are more  heterogeneous
round the catheter in nature which results in a poor cos-
etic effect in the patients. Hence, it is of major concern in
he brachytherapy, particularly when a free hand application
appens to be the only available option in the institution.
The use of EBRT in APBI resulted in more  homogenous dose
istribution without compromising the dose conformity. The
ritical organ doses were also minimal which was similar to
he dose distribution achieved with brachytherapy interstitial
mplants. It was clearly manifested by statistically less signif-
cant p values and optimal conﬁdence level (t0.975 or t = 0.05)
ttained with the dose volume parameters.
The dose escalation of about 600cGy per fraction with con-
ormal external beam radiotherapy paves the way for a better
umour control. Hence, it can be treatment of choice when a
on invasive procedure is preferred. The set up uncertainties
n the external beam radiotherapy procedure can be effec-
ively overcome by daily treatment veriﬁcation methods (Porttherapy 1 7 ( 2 0 1 2 ) 200–206 205
ﬁlms, EPID), immobilisation devices and with an added target
volume margins.
6.  Conclusions
This is a small sub set treatment planning feasibility study
comprising of ﬁfteen patient cases simulated with EBRT plans.
The dose distribution planned was compared with the high
dose rate brachytherapy planning. It gives satisfying results of
dose conformity and dose homogeneity to the tumour volume
with acceptable sparing of normal tissues based on the statis-
tical analysis. Hence, the APBI can be effectively planned using
the three dimensional conformal external beam radiation
therapy. Patient discomfort during brachytherapy procedures
involving sedation and a poor cosmetic effect after irradiation
can be avoided. Conformal EBRT course is more  cost effective
when compared to brachytherapy. Hence, it can be suggested
as an alternative treatment modality where brachytherapy
procedures are performed freehand which is tedious in nature.
Enduring research will focus on the evaluation of Tumour Con-
trol Probability and Normal Tissue Complication Probability in
EBRT and brachytherapy plans.
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